Year-end Sale % OFF 
Abstract
Unlike GnRH agonist in vitro fertilization (IVF) cycles, antagonist cycles provide two options to stimulate final oocyte maturation (“trigger”): (1) recombinant hCG (recHCG) or (2) induction of an endogenous LH surge through administration of a GnRH agonist (GnRHa). The aim of this study was to compare progesterone rise, oocyte maturation, blastulation, and embryo yield in patients undergoing their first antagonist cycle who received recHCG versus GnRHa to induce oocyte maturation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
